These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 33378972)

  • 1. Pharmacological inhibition of focal adhesion kinase 1 (FAK1) and anaplastic lymphoma kinase (ALK) identified via kinome profile analysis attenuates lipopolysaccharide-induced endothelial inflammatory activation.
    Dayang EZ; Luxen M; Kuiper T; Yan R; Rangarajan S; van Meurs M; Moser J; Molema G
    Biomed Pharmacother; 2021 Jan; 133():111073. PubMed ID: 33378972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological inhibitors of anaplastic lymphoma kinase (ALK) induce immunogenic cell death through on-target effects.
    Petrazzuolo A; Perez-Lanzon M; Martins I; Liu P; Kepp O; Minard-Colin V; Maiuri MC; Kroemer G
    Cell Death Dis; 2021 Jul; 12(8):713. PubMed ID: 34272360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental differences in focal adhesion kinase expression modulate pulmonary endothelial barrier function in response to inflammation.
    Ying L; Alvira CM; Cornfield DN
    Am J Physiol Lung Cell Mol Physiol; 2018 Jul; 315(1):L66-L77. PubMed ID: 29597831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK.
    Chang LS; Oblinger JL; Smith AE; Ferrer M; Angus SP; Hawley E; Petrilli AM; Beauchamp RL; Riecken LB; Erdin S; Poi M; Huang J; Bessler WK; Zhang X; Guha R; Thomas C; Burns SS; Gilbert TSK; Jiang L; Li X; Lu Q; Yuan J; He Y; Dixon SAH; Masters A; Jones DR; Yates CW; Haggarty SJ; La Rosa S; Welling DB; Stemmer-Rachamimov AO; Plotkin SR; Gusella JF; Guinney J; Morrison H; Ramesh V; Fernandez-Valle C; Johnson GL; Blakeley JO; Clapp DW;
    PLoS One; 2021; 16(7):e0252048. PubMed ID: 34264955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological inhibition of IRAK1 and IRAK4 prevents endothelial inflammation and atherosclerosis in ApoE
    Wu X; Xu M; Liu Z; Zhang Z; Liu Y; Luo S; Zheng X; Little PJ; Xu S; Weng J
    Pharmacol Res; 2022 Jan; 175():106043. PubMed ID: 34954030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and preclinical characterization of novel small molecule TRK and ROS1 tyrosine kinase inhibitors for the treatment of cancer and inflammation.
    Narayanan R; Yepuru M; Coss CC; Wu Z; Bauler MN; Barrett CM; Mohler ML; Wang Y; Kim J; Snyder LM; He Y; Levy N; Miller DD; Dalton JT
    PLoS One; 2013; 8(12):e83380. PubMed ID: 24386191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidic Acid Stimulates Mitogenic Activity and Signaling in Human Neuroblastoma Cells through a Crosstalk with Anaplastic Lymphoma Kinase.
    Dedoni S; Olianas MC; Onali P
    Biomolecules; 2024 May; 14(6):. PubMed ID: 38927035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaplastic Lymphoma Kinase signaling stabilizes SLC3A2 expression via MARCH11 to promote neuroblastoma cell growth.
    Lai WY; Chuang TP; Borenäs M; Lind DE; Hallberg B; Palmer RH
    Cell Death Differ; 2024 Jul; 31(7):910-923. PubMed ID: 38858548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidating the role of the kinase activity of endothelial cell focal adhesion kinase in angiocrine signalling and tumour growth.
    Newport E; Pedrosa AR; Lees D; Dukinfield M; Carter E; Gomez-Escudero J; Casado P; Rajeeve V; Reynolds LE; R Cutillas P; Duffy SW; De Luxán Delgado B; Hodivala-Dilke K
    J Pathol; 2022 Feb; 256(2):235-247. PubMed ID: 34743335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neuronal receptor tyrosine kinase Alk is a target for longevity.
    Woodling NS; Aleyakpo B; Dyson MC; Minkley LJ; Rajasingam A; Dobson AJ; Leung KHC; Pomposova S; Fuentealba M; Alic N; Partridge L
    Aging Cell; 2020 May; 19(5):e13137. PubMed ID: 32291952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Anaplastic Lymphoma Kinase Protects From Ischemic Stroke.
    Hu Y; Chang L; Zhu Y; Geng X; Liu Z; Wang R; Wang Y; Zhao BQ; Fan W
    Stroke; 2024 Apr; 55(4):1075-1085. PubMed ID: 38445502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review on Anaplastic Lymphoma Kinase (ALK) Rearrangements and Mutations: Implications for Gastric Carcinogenesis and Target Therapy.
    Mesquita FP; Lima LB; da Silva EL; Souza PFN; de Moraes MEA; Burbano RMR; Montenegro RC
    Curr Protein Pept Sci; 2024; 25(7):539-552. PubMed ID: 38424421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALK and RET Inhibitors Promote HLA Class I Antigen Presentation and Unmask New Antigens within the Tumor Immunopeptidome.
    Oh CY; Klatt MG; Bourne C; Dao T; Dacek MM; Brea EJ; Mun SS; Chang AY; Korontsvit T; Scheinberg DA
    Cancer Immunol Res; 2019 Dec; 7(12):1984-1997. PubMed ID: 31540894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing Dual Inhibitors of Anaplastic Lymphoma Kinase (ALK) and Bromodomain-4 (BRD4) by Tuning Kinase Selectivity.
    Watts E; Heidenreich D; Tucker E; Raab M; Strebhardt K; Chesler L; Knapp S; Bellenie B; Hoelder S
    J Med Chem; 2019 Mar; 62(5):2618-2637. PubMed ID: 30789735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Alk receptor tyrosine kinase regulates Sparkly, a novel activity regulating neuropeptide precursor in the
    Sukumar SK; Antonydhason V; Molander L; Sandakly J; Kleit M; Umapathy G; Mendoza-Garcia P; Masudi T; Schlosser A; Nässel DR; Wegener C; Shirinian M; Palmer RH
    Elife; 2024 Jun; 12():. PubMed ID: 38904987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifaceted Roles of ALK Family Receptors and Augmentor Ligands in Health and Disease: A Comprehensive Review.
    Katic L; Priscan A
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMBRA1 levels predict resistance to MAPK inhibitors in melanoma.
    Di Leo L; Pagliuca C; Kishk A; Rizza S; Tsiavou C; Pecorari C; Dahl C; Pacheco MP; Tholstrup R; Brewer JR; Berico P; Hernando E; Cecconi F; Ballotti R; Bertolotto C; Filomeni G; Gjerstorff MF; Sauter T; Lovat P; Guldberg P; De Zio D
    Proc Natl Acad Sci U S A; 2024 Jun; 121(25):e2400566121. PubMed ID: 38870061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaplastic Lymphoma Kinase (ALK) Receptor Tyrosine Kinase: A Catalytic Receptor with Many Faces.
    Huang H
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ecklonia cava extracts inhibit lipopolysaccharide induced inflammatory responses in human endothelial cells.
    Kim TH; Bae JS
    Food Chem Toxicol; 2010 Jun; 48(6):1682-7. PubMed ID: 20363280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting endothelial cell Mst1 attenuates acute lung injury in mice.
    Guo ZF; Tongmuang N; Li C; Zhang C; Hu L; Capreri D; Zuo MX; Summer R; Sun J
    bioRxiv; 2023 Sep; ():. PubMed ID: 37808846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.